NEXGEL, INC. Logo

NEXGEL, INC.

Develops and manufactures advanced hydrogels for healthcare, OTC, and consumer applications.

NXGL | US

Overview

Corporate Details

ISIN(s):
US65344E1073
LEI:
Country:
United States of America
Address:
2150 CABOT BLVD WEST,, 19047 LANGHORNE
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

NEXGEL, Inc. is a technology company that develops and manufactures advanced, high-water-content hydrogels. Utilizing an electron-beam cross-linking process, the company produces ultra-gentle hydrogel products for healthcare, over-the-counter (OTC), and consumer applications. Its versatile platform is used for wound care, transdermal delivery of active ingredients, beauty and cosmetic treatments, and foot care. Operating from an FDA-registered and ISO-certified cGMP manufacturing facility, NEXGEL offers a range of proprietary formulations, including biodegradable options, and provides custom development services for business partners to deliver their unique ingredients via a hydrogel system.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all NEXGEL, INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for NEXGEL, INC.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for NEXGEL, INC. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

MaaT Pharma Logo
Developing gut microbiome therapies to improve survival for cancer patients.
France
MAAT
Mabion S.A. Logo
Global CDMO providing end-to-end services for developing and manufacturing complex biologic drugs.
Poland
MAB
MACROGENICS INC Logo
Biopharma firm developing innovative antibody-based therapeutics for cancer treatment.
United States of America
MGNX
MADRIGAL PHARMACEUTICALS, INC. Logo
Develops and delivers the first FDA-approved treatment for the liver disease MASH.
United States of America
MDGL
Magle Chemoswed Holding AB Logo
A CDMO for pharma/med device firms, offering end-to-end development and specialized manufacturing.
Sweden
MAGLE
Develops at-home diagnostic tests for the early detection of life-threatening cancers.
Germany
MYNZ
MANNKIND CORP Logo
Develops inhaled therapies for endocrine, orphan lung, and cardiometabolic diseases.
United States of America
MNKD
MARAVAI LIFESCIENCES HOLDINGS, INC. Logo
Provides nucleic acid products and biologics safety testing for new therapies and vaccines.
United States of America
MRVI
Marinomed Biotech AG Logo
Develops virus-blocking products & immunology therapies via proprietary technology platforms.
Austria
MARI
Marker Therapeutics, Inc. Logo
Developing non-genetically modified T cell immunotherapies for hematologic and solid tumors.
United States of America
MRKR

Talk to a Data Expert

Have a question? We'll get back to you promptly.